Elite Diagnostic Limited (JMSE:ELITE)
Jamaica · Delayed Price · Currency is JMD 1.050
-0.060 (-5.41%)
At close: Jun 12, 2026
Elite Diagnostic Cash Flow Statement
Financials in millions JMD. Fiscal year is July - June.
Millions JMD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 48.88 | 32.02 | 26.16 | 13.35 | 48.66 | 1.93 |
Depreciation & Amortization | 172.86 | 166.19 | 132.16 | 136.5 | 104.93 | 100.01 |
Other Amortization | 3.92 | 3.92 | 3.07 | -0.06 | 2.59 | 2.05 |
Other Operating Activities | 3.62 | 0.28 | 3.04 | -0.06 | -0.01 | - |
Change in Accounts Receivable | 30.75 | 57.09 | -25.85 | -57.22 | -17.5 | -0.25 |
Change in Accounts Payable | -61.1 | 3.66 | 18.17 | 29.88 | 9.56 | 21.95 |
Change in Other Net Operating Assets | 0.48 | -2.59 | 8.07 | -10.51 | -0.32 | -0.64 |
Operating Cash Flow | 182.85 | 260.57 | 164.81 | 111.88 | 147.92 | 125.04 |
Operating Cash Flow Growth | -15.23% | 58.10% | 47.31% | -24.36% | 18.29% | 87.30% |
Capital Expenditures | -108.44 | -92.62 | -72.53 | -137.75 | -275.79 | -86.24 |
Other Investing Activities | 1.1 | 0.13 | 0.09 | -20.41 | 0.01 | - |
Investing Cash Flow | -107.35 | -92.49 | -72.44 | -158.15 | -275.78 | -86.24 |
Short-Term Debt Issued | - | 9.74 | 14.09 | 9.14 | 5.83 | - |
Long-Term Debt Issued | - | 400 | - | 365.42 | 190 | - |
Total Debt Issued | 409.08 | 409.74 | 14.09 | 374.56 | 195.83 | - |
Short-Term Debt Repaid | - | -11.57 | -10.52 | -8.37 | - | - |
Long-Term Debt Repaid | - | -377.92 | -112.6 | -334.86 | -24.26 | -14.03 |
Total Debt Repaid | -339.41 | -389.49 | -123.12 | -343.23 | -24.26 | -14.03 |
Net Debt Issued (Repaid) | 69.67 | 20.25 | -109.04 | 31.33 | 171.57 | -14.03 |
Common Dividends Paid | - | - | - | -7.07 | -31.81 | - |
Financing Cash Flow | 69.67 | 20.25 | -109.04 | 24.27 | 139.76 | -14.03 |
Net Cash Flow | 145.17 | 188.33 | -16.66 | -22.01 | 11.9 | 24.78 |
Free Cash Flow | 74.41 | 167.95 | 92.29 | -25.87 | -127.87 | 38.8 |
Free Cash Flow Growth | -47.41% | 81.98% | - | - | - | - |
Free Cash Flow Margin | 8.50% | 19.67% | 11.24% | -3.43% | -20.48% | 7.65% |
Free Cash Flow Per Share | 0.21 | 0.47 | 0.26 | -0.07 | -0.36 | 0.11 |
Cash Interest Paid | 43.95 | 39.14 | 62.79 | 46.87 | 27.33 | 21.02 |
Cash Income Tax Paid | 0.67 | 0.31 | 0.07 | - | - | - |
Levered Free Cash Flow | 40.22 | 163.65 | 93.6 | -19.1 | -142.07 | 42.22 |
Unlevered Free Cash Flow | 61.48 | 181.3 | 124 | 1.32 | -124.99 | 55.36 |
Change in Working Capital | -46.42 | 58.16 | 0.39 | -37.86 | -8.26 | 21.05 |